Table 2.
|
Homogenate TFV |
Homogenate TFV-DP |
Total Cell TFV-DP |
CD4+ Cells TFV-DP |
||||
---|---|---|---|---|---|---|---|---|
Days | N>0 | Median (IQR) | N>0 | Median (IQR) | N>0 | Median (IQR) | N>0 | Median (IQR) |
1 | 5 | 33.8 (6.8, 37.8)* | 5 | 123.7 (8.4, 155.4)* | 5 | 0.3 (0.1, 0.4) | 2 | 19.2 (9.6, 28.8) |
8 | 6 | 4.5 (0.9, 31.3) | 5 | 1.7 (0.3, 2.8) | 4 | 1.1 (0.8, 1.4) | 2 | 0.2 (0.2, 0.2) |
15 | 1 | 0.3 | 2 | 2.6 (2.5, 2.6) | 4 | 0.3 (0.1, 0.5)* | 1 | 0.2 |
Values are median (interquartile range [IQR]) except where N = 2 where minimum and maximum are shown, and where N = 1 where IQR is not shown; TFV, tenofovir; N>0, number of participants with complete non-zero value (above limits of assay quantitation) for both colon and vaginal drug concentration; TFV-DP, tenofovir diphosphate; *p < 0.05.